Ding L - Search Results

1

Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer.

Tang S, Hang Y, Ding L, Tang W, Yu A, Zhang C, Sil D, Xie Y, Oupický D. Tang S, et al. Among authors: ding l. Mol Pharm. 2021 Dec 6;18(12):4448-4458. doi: 10.1021/acs.molpharmaceut.1c00653. Epub 2021 Oct 26. Mol Pharm. 2021. PMID: 34699242 Free PMC article.

2

Oral Nanostructured Lipid Carriers Loaded with Near-Infrared Dye for Image-Guided Photothermal Therapy.

Chen G, Wang K, Zhou Y, Ding L, Ullah A, Hu Q, Sun M, Oupický D. Chen G, et al. Among authors: ding l. ACS Appl Mater Interfaces. 2016 Sep 28;8(38):25087-95. doi: 10.1021/acsami.6b07425. Epub 2016 Sep 14. ACS Appl Mater Interfaces. 2016. PMID: 27626389

3

Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery.

Chen G, Wang K, Hu Q, Ding L, Yu F, Zhou Z, Zhou Y, Li J, Sun M, Oupický D. Chen G, et al. Among authors: ding l. ACS Appl Mater Interfaces. 2017 Feb 8;9(5):4457-4466. doi: 10.1021/acsami.6b14184. Epub 2017 Jan 30. ACS Appl Mater Interfaces. 2017. PMID: 28135066

4

Pulmonary delivery of polyplexes for combined PAI-1 gene silencing and CXCR4 inhibition to treat lung fibrosis.

Ding L, Zhu C, Yu F, Wu P, Chen G, Ullah A, Wang K, Sun M, Li J, Oupický D. Ding L, et al. Nanomedicine. 2018 Aug;14(6):1765-1776. doi: 10.1016/j.nano.2018.05.005. Epub 2018 May 16. Nanomedicine. 2018. PMID: 29777878

5

Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.

Li Z, Chen G, Ding L, Wang Y, Zhu C, Wang K, Li J, Sun M, Oupicky D. Li Z, et al. Among authors: ding l. Mol Ther. 2019 Dec 4;27(12):2100-2110. doi: 10.1016/j.ymthe.2019.08.008. Epub 2019 Aug 22. Mol Ther. 2019. PMID: 31481310 Free PMC article.

6

Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.

Wang Y, Ding L, Li Z, Chen G, Sun M, Oupicky D. Wang Y, et al. Among authors: ding l. J Control Release. 2019 Nov 28;314:12-24. doi: 10.1016/j.jconrel.2019.10.030. Epub 2019 Oct 20. J Control Release. 2019. PMID: 31644934

7

Pulmonary siRNA delivery for lung disease: Review of recent progress and challenges.

Ding L, Tang S, Wyatt TA, Knoell DL, Oupický D. Ding L, et al. J Control Release. 2021 Feb 10;330:977-991. doi: 10.1016/j.jconrel.2020.11.005. Epub 2020 Nov 9. J Control Release. 2021. PMID: 33181203 Review.

8

Preferential siRNA delivery to injured kidneys for combination treatment of acute kidney injury.

Tang W, Chen Y, Jang HS, Hang Y, Jogdeo CM, Li J, Ding L, Zhang C, Yu A, Yu F, Foster KW, Padanilam BJ, Oupický D. Tang W, et al. Among authors: ding l. J Control Release. 2022 Jan;341:300-313. doi: 10.1016/j.jconrel.2021.11.029. Epub 2021 Nov 23. J Control Release. 2022. PMID: 34826532 Free PMC article.

9

Perfluorocarbon Nanoemulsions Enhance Therapeutic siRNA Delivery in the Treatment of Pulmonary Fibrosis.

Ding L, Tang S, Tang W, Mosley DD, Yu A, Sil D, Romanova S, Bailey KL, Knoell DL, Wyatt TA, Oupický D. Ding L, et al. Adv Sci (Weinh). 2022 Mar;9(8):e2103676. doi: 10.1002/advs.202103676. Epub 2022 Jan 7. Adv Sci (Weinh). 2022. PMID: 34994102 Free PMC article.

10

Nanoemulsion-Assisted siRNA Delivery to Modulate the Nervous Tumor Microenvironment in the Treatment of Pancreatic Cancer.

Ding L, Tang S, Yu A, Wang A, Tang W, Jia H, Oupický D. Ding L, et al. ACS Appl Mater Interfaces. 2022 Mar 2;14(8):10015-10029. doi: 10.1021/acsami.1c21997. Epub 2022 Feb 21. ACS Appl Mater Interfaces. 2022. PMID: 35188730 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,362 results

Search Page

Filters